US38141G1040 - Common Stock

Taking everything into account, **GS** scores **3** out of 10 in our fundamental rating. **GS** was compared to 220 industry peers in the **Capital Markets** industry. Both the profitability and financial health of **GS** have multiple concerns. **GS** has a correct valuation and a medium growth rate.

Each year in the past 5 years **GS** has been profitable.

The reported operating cash flow has been mixed in the past 5 years: **GS** reported negative operating cash flow in multiple years.

With a **Return On Assets** value of **0.52%**, **GS** is not doing good in the industry: **73.95%** of the companies in the same industry are doing better.

Looking at the **Return On Invested Capital**, with a value of **0.77%**, **GS** is doing worse than **77.67%** of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 0.52% | ||

ROE | 7.38% | ||

ROIC | 0.77% |

ROA(3y)0.89%

ROA(5y)0.85%

ROE(3y)11.73%

ROE(5y)10.65%

ROIC(3y)1.19%

ROIC(5y)1.21%

Looking at the **Profit Margin**, with a value of **7.60%**, **GS** is doing worse than **68.37%** of the companies in the same industry.

In the last couple of years the **Profit Margin** of **GS** has declined.

In the last couple of years the **Operating Margin** of **GS** has declined.

The **Gross Margin** of **GS** (**36.85%**) is worse than **70.23%** of its industry peers.

Industry Rank | Sector Rank | ||
---|---|---|---|

OM | 10.98% | ||

PM (TTM) | 7.6% | ||

GM | 36.85% |

OM growth 3Y-27.82%

OM growth 5Y-15.03%

PM growth 3Y-22.75%

PM growth 5Y-17.02%

GM growth 3Y-21.32%

GM growth 5Y-10.2%

The number of shares outstanding for **GS** has been reduced compared to 5 years ago.

Compared to 1 year ago, **GS** has a worse debt to assets ratio.

Based on the Altman-Z score of **-0.27**, we must say that **GS** is in the distress zone and has some risk of bankruptcy.

With a **Altman-Z score** value of **-0.27**, **GS** is not doing good in the industry: **86.05%** of the companies in the same industry are doing better.

A Debt/Equity ratio of **8.62** is on the high side and indicates that **GS** has dependencies on debt financing.

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 8.62 | ||

Debt/FCF | N/A | ||

Altman-Z | -0.27 |

ROIC/WACCN/A

WACCN/A

The **Quick ratio** of **GS** (**0.33**) is worse than **79.53%** of its industry peers.

Industry Rank | Sector Rank | ||
---|---|---|---|

Current Ratio | 0.33 | ||

Quick Ratio | 0.33 |

The **Revenue** has grown by **32.19%** in the past year. This is a very strong growth!

Measured over the past years, **GS** shows a quite strong growth in **Revenue**. The Revenue has been growing by **15.31%** on average per year.

EPS 1Y (TTM)27.04%

EPS 3Y-8.43%

EPS 5Y-1.09%

EPS Q2Q%179.87%

Revenue 1Y (TTM)32.19%

Revenue growth 3Y24.38%

Revenue growth 5Y15.31%

Sales Q2Q%16.85%

Based on estimates for the next years, **GS** will show a small growth in **Revenue**. The Revenue will grow by **2.15%** on average per year.

EPS Next Y58.95%

EPS Next 2Y33.84%

EPS Next 3Y25.43%

EPS Next 5Y11.54%

Revenue Next Year12.82%

Revenue Next 2Y8.82%

Revenue Next 3Y7.01%

Revenue Next 5Y2.15%

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

With a **Price/Earnings** ratio of **15.74**, **GS** is valued correctly.

When comparing the **Price/Earnings** ratio of **GS** to the average of the S&P500 Index (**28.79**), we can say **GS** is valued slightly cheaper.

Compared to the rest of the industry, the **Price/Forward Earnings** ratio of **GS** is on the same level as its industry peers.

The average S&P500 **Price/Forward Earnings** ratio is at **20.38**. **GS** is valued slightly cheaper when compared to this.

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 15.74 | ||

Fwd PE | 11.45 |

Industry Rank | Sector Rank | ||
---|---|---|---|

P/FCF | N/A | ||

EV/EBITDA | 16.01 |

The low **PEG Ratio(NY)**, which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.

A more expensive valuation may be justified as **GS**'s earnings are expected to grow with **25.43%** in the coming years.

PEG (NY)0.27

PEG (5Y)N/A

EPS Next 2Y33.84%

EPS Next 3Y25.43%

With a **Yearly Dividend Yield** of **2.40%**, **GS** has a reasonable but not impressive dividend return.

Compared to an average industry **Dividend Yield** of **7.64**, **GS** is paying slightly less dividend.

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 2.4% |

The dividend of **GS** is nicely growing with an annual growth rate of **21.17%**!

Dividend Growth(5Y)21.17%

Div Incr Years12

Div Non Decr Years13

DP49.13%

EPS Next 2Y33.84%

EPS Next 3Y25.43%

**GOLDMAN SACHS GROUP INC**

NYSE:GS (8/9/2024, 7:04:00 PM)

After market: 490.99 +0.73 (+0.15%)**490.26**

**+4.49 (+0.92%) **

Chartmill FA Rating

GICS SectorFinancials

GICS IndustryGroupFinancial Services

GICS IndustryCapital Markets

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap158.09B

Analysts

Price Target

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 2.4% |

Dividend Growth(5Y)

DP

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 15.74 | ||

Fwd PE | 11.45 | ||

P/S | |||

P/FCF | |||

P/OCF | |||

P/B | |||

P/tB | |||

EV/EBITDA |

EPS(TTM)

EY

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)0.27

PEG (5Y)N/A

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 0.52% | ||

ROE | 7.38% | ||

ROCE | |||

ROIC | |||

ROICexc | |||

ROICexgc | |||

OM | 10.98% | ||

PM (TTM) | 7.6% | ||

GM | 36.85% | ||

FCFM |

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.07

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 8.62 | ||

Debt/FCF | |||

Debt/EBITDA | |||

Cap/Depr | |||

Cap/Sales | |||

Interest Coverage | |||

Cash Conversion | |||

Profit Quality | |||

Current Ratio | 0.33 | ||

Quick Ratio | 0.33 | ||

Altman-Z |

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

High Growth Momentum

Growth

EPS 1Y (TTM)27.04%

EPS 3Y-8.43%

EPS 5Y

EPS Q2Q%

EPS Next Y58.95%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)32.19%

Revenue growth 3Y24.38%

Revenue growth 5Y

Sales Q2Q%

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y